473 related articles for article (PubMed ID: 10798756)
1. Sensitization and sensitivity: defining the unsensitized patient.
Gebel HM; Bray RA
Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch.
Karpinski M; Rush D; Jeffery J; Exner M; Regele H; Dancea S; Pochinco D; Birk P; Nickerson P
J Am Soc Nephrol; 2001 Dec; 12(12):2807-2814. PubMed ID: 11729251
[TBL] [Abstract][Full Text] [Related]
5. Multilaboratory evaluation of serum analysis for HLA antibody and crossmatch reactivity by lymphocytotoxicity methods.
Duquesnoy RJ; Marrari M
Arch Pathol Lab Med; 2003 Feb; 127(2):149-56. PubMed ID: 12562227
[TBL] [Abstract][Full Text] [Related]
6. Comparative study between cytotoxicity and flowcytometry crossmatches before and after renal transplantation.
Abdel Rahman AS; Fahim NM; El Sayed AA; El Hady SA; Ahmad YS
Egypt J Immunol; 2005; 12(2):77-89. PubMed ID: 17977213
[TBL] [Abstract][Full Text] [Related]
7. Panel-reactive antibody screening practices prior to heart transplantation.
Betkowski AS; Graff R; Chen JJ; Hauptman PJ
J Heart Lung Transplant; 2002 Jun; 21(6):644-50. PubMed ID: 12057697
[TBL] [Abstract][Full Text] [Related]
8. The Pre-Transplant Drop in Panel-Reactive Antibodies Titer Evaluated Using Complement-Dependent Cytotoxicity (PRA-CDC) and the Risk of Early Acute Rejection in Sensitized Kidney Transplant Recipients.
Kolonko A; Bzoma B; Giza P; Styrc B; Sobolewski M; Chudek J; Dębska-Ślizień A; Więcek A
Medicina (Kaunas); 2018 Sep; 54(5):. PubMed ID: 30344297
[No Abstract] [Full Text] [Related]
9. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
Won DI; Jeong HD; Kim YL; Suh JS
Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
[TBL] [Abstract][Full Text] [Related]
10. Crossmatch procedures used in organ transplantation.
Gebel HM; Lebeck LK
Clin Lab Med; 1991 Sep; 11(3):603-20. PubMed ID: 1934966
[TBL] [Abstract][Full Text] [Related]
11. Kidney transplantation with positive complement-dependent lymphocytotoxicity crossmatch with negative flow crossmatching and Luminexx donor-specific antibodies.
Kute VB; Vanikar AV; Gumber MR; Trivedi VB; Shah PR; Patel HV; Balwani MR; Modi PR; Trivedi HL
Ren Fail; 2013 Aug; 35(7):1027-30. PubMed ID: 23829775
[TBL] [Abstract][Full Text] [Related]
12. Flow-PRA evaluation for antibody screening in patients awaiting kidney transplantation.
Rebibou JM; Chabod J; Bittencourt MC; Thevénin C; Chalopin JM; Hervé P; Tiberghien P
Transpl Immunol; 2000 Jun; 8(2):125-8. PubMed ID: 11005318
[TBL] [Abstract][Full Text] [Related]
13. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD
Transplantation; 2004 Jul; 78(2):221-7. PubMed ID: 15280682
[TBL] [Abstract][Full Text] [Related]
14. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
[TBL] [Abstract][Full Text] [Related]
15. Effect of panel-reactive antibody in predicting crossmatch selection of cadaveric kidney recipients.
Lieber SR; Perez FV; Tabossi MR; Persoli LB; Marques SB; Mazzali M; Alves-Filho G; de Souza CA
Transplant Proc; 2007 Mar; 39(2):429-31. PubMed ID: 17362748
[TBL] [Abstract][Full Text] [Related]
16. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
Barocci S; Valente U; Nocera A
Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
[TBL] [Abstract][Full Text] [Related]
18. Long-term kidney graft survival across a positive historic but negative current sensitized cross-match.
Baron C; Pastural M; Lang P; Bentabet R; el-Kassar N; Seror T; Dahmane D; Desvaux D; Chopin D; Fruchaud G; Remy P; Grimbert P; Lepage E; Bierling P
Transplantation; 2002 Jan; 73(2):232-6. PubMed ID: 11821736
[TBL] [Abstract][Full Text] [Related]
19. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
[TBL] [Abstract][Full Text] [Related]
20. Complement-dependent cytotoxicity crossmatch in solid organ transplantation: The gold standard or golden history?
Tafulo S; Osório E; Mendes C; Liwski R
Hum Immunol; 2024 Jan; 85(1):110734. PubMed ID: 38030522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]